参考文献/References:
[1]Goto Y,Yoshida T,Kimura M.Higher efficacy and complete response with administration of eribulin for recurrent squamous cell breast carcinoma:A case report[J].Molecular and Clinical Oncology,2018,9(3):318-320. [2]Jakubowska K,Kańczuga-Koda L,Kisielewski W,et al.Squamous cell carcinoma of the breast as a clinical diagnostic challenge[J].Mol Clin Oncol,2018,8(4):587-591. [3]Yoneto T,Hasumi K,Yoshimoto T,et al.Case report:two cases of extremely rare primary pure squamous cell carcinoma of the breast[J].Medicine(Baltimore),2018,97(37):e12340. [4]Avigdor BE,Beierl K,Gocke CD,et al.Whole-Exome Sequencing of Metaplastic Breast Carcinoma Indicates Monoclonality with Associated Ductal Carcinoma Component[J].Clinical Cancer Research,2017,23(16):4875-4884. [5]Piscuoglio S,Ng CKY,Geyer FC,et al.Genomic and transcriptomic heterogeneity in metaplastic carcinomas of the breast[J].NPJ Breast Cancer,2017(3):48. [6]Ng CKY,Piscuoglio S,Geyer Felipe C,et al.The landscape of somatic genetic alterations in Metaplastic breast carcinomas[J].Clin Cancer Res,2017,23(14):3859-3870. [7]Yadav S,Yadav D,Zakalik D.Squamous cell carcinoma of the breast in the United States:incidence,demographics,tumor characteristics,and survival[J].Breast Cancer Res Treat 2017,164(1):201-208. [8]Zhou YM,Chaudhry HE,Shah A,et al.Breast Squamous Cell Carcinoma Following Breast Augmentation[J].Cureus,2018,(10)10:e3405. [9]Punzo C,Fortarezza F,De Ruvo V,et al.Primitivesquamous cell carcinoma of the breast(SCCB): case report of an uncommon variant of metaplastic carcinoma[J].Clinical practice.2017,38(3):139-142. [10]Bhosale SJ,Kshirsagar AY,Deshmukh SJ,et al.Squamous cell carcinoma of the breast[J].Am J Case Rep,2013(14):188-190. [11]Lakhani SR,Ellis IO,Schnitt SJ,et al.views of a working group that convened for a consensus and editorial meeting at the International Agency for Research on Cancer[M]// WHO classification of tumours of the breast.IARC Press,WHO,Lyon,2012. [12]Candelaria RP,Krishnamurthy S,Huang ML,et al.Imaging and pathological findings in a case of invasive squamous cell carcinoma of the breast[J].Breast J,2018,24(2):203-204. [13]杨倩,朱庆莉,姜玉新,等.乳腺原发性鳞状细胞癌的临床、病理及超声特征[J].中华医学超声杂志,2015,12(5):408-412. [14]Kashiwagi S,Okuno T,Ishihara S,et al.Effectiveness of eribulin chemotherapy for squamous cell carcinoma of the breast(Japanese)[J].Gan To Kagaku Ryoho,2013,40(12):2369-2371. [15]Motamedolshariati M,Memar B,Aliakbaian M,et al.Accuracy of prognostic and predictive markers in core needle breast biopsies compared with excisional specimens[J].Breast Care(Basel),2014,9(2):107-110. [16]Silverstein MJ,Recht A,Lagios MD,et al.Special report:Consensus conferenceⅢ.Image-detected breast cancer:state-of-the-art diagnosis and treatment[J].J Am Coll Surg, 2009,209(4):504-520. [17]Stephen P Povoski,Rafael E Jimenez,Wenle P Wang.Ultrasound-guided diagnostic breast biopsy methodology:retrospective comparison of the 8-gauge vacuum-assisted biopsy approach versus the spring-loaded 14-gauge core biopsy approach[J].World J Surg Oncol,2011(9):87. [18]杜军,丁敏,李恒,等.乳腺化生性癌6例临床病理分析[J].诊断病理学杂志,2015,22(1):12-15. [19]吴海清,胡巧娟,陆爱权.原发性乳腺单纯鳞状细胞癌1例并文献复习[J].中国老年学杂志,2016,36(4):972-973. [20]Shui R,Li A,Yang F,et al.Primary squamous cell carcinoma of the breast with unusual basal-HER2 phenotype[J].Int J Clin Exp Pathol,2014,7(8):5203-5209. [21]Benoist P,Mureau A,Joueidi Y,et al.Management and prognosis of pure primary squamous cell carcinoma of the breast[J].null,2018,47(7):275-280. [22]Behranwala KA,Nasiri N,Abdullah N,et al.Squamous cell carcinoma of the breast: clinico-pathologic implications and outcome[J].Eur J Surg Oncol,2003,29(4):386-389. [23]Liling Zhu，Kai Chen.Clinicopathological features,treatment patterns,and prognosis of squamous cell carcinoma of the breast:an NCDB analysis[J].BMC Cancer 2019,19(1):26. [24]Hennessy BT,Krishnamurthy S,Giordano S,et al.Squamous cell carcinoma of the breast[J].Journal of clinical oncology,2005,23(31):7827-7835. [25]Liu J,Yu Y,Sun JY,et al.Clinicopathologic characteristics and prognosis of primary squamous cell carcinoma of the breast[J].Breast Cancer Res Treat,2015,149(1):133-140. [26]Wang J,Zhang X,He J,et al.Co-expression of EGFR and CK5/6 in primary squamous cell carcinoma of the breast[J].Med Oncol,2014,31(9):172. [27]Bhatt L,Fernando I.Primary squamous cell carcinoma of the breast:achieving long-term control with cisplatin-based chemotherapy[J].Clin Breast Cancer,2009,9(3):187-188. [28]Alan O,Telli TA,Ercelep O,et al.A case of primary squamous cell carcinoma of the breast with pathologic complete response after neoadjuvant chemotherapy[J]. Curr Probl Cancer,2019,43(4):308-311.
相似文献/References:
[1]张如意.动脉瘤样纤维组织细胞瘤4例临床病理观察[J].医学信息,2019,32(01):173.[doi:10.3969/j.issn.1006-1959.2019.01.055]
ZHANG Ru-yi.Clinicopathological Observation of 4 Cases of Aneurysmal Fibroblastoma[J].Medical Information,2019,32(03):173.[doi:10.3969/j.issn.1006-1959.2019.01.055]
[2]高 协.胃癌中表皮生长因子受体2蛋白表达与临床病理特征的关系[J].医学信息,2020,33(13):57.[doi:10.3969/j.issn.1006-1959.2020.13.016]
GAO Xie.Relationship Between Epidermal Growth Factor Receptor 2 Protein Expression and Clinicopath-ological Characteristics in Gastric Cancer[J].Medical Information,2020,33(03):57.[doi:10.3969/j.issn.1006-1959.2020.13.016]
[3]张文娟,郭永泽,程丽敏,等.miR-106b-3p和miR-214在食管鳞癌组织中的表达及其与临床病理特征的关系[J].医学信息,2021,34(03):116.[doi:10.3969/j.issn.1006-1959.2021.03.032]
ZHANG Wen-juan,GUO Yong-ze,CHENG Li-min,et al.The Epression of miR-106b-3p and miR-214 in Esophageal Squamous Cell Carcinoma and Its Relationship with Clinicopathological Characteristics[J].Medical Information,2021,34(03):116.[doi:10.3969/j.issn.1006-1959.2021.03.032]
[4]李东松,陈娉珊,蔡泰楠,等.错配修复蛋白表达缺失与结直肠癌病理特征及预后的关系[J].医学信息,2024,37(08):99.[doi:10.3969/j.issn.1006-1959.2024.08.019]
LI Dong-song,CHEN Ping-shan,CAI Tai-nan,et al.Relationship Between the Loss of Mismatch Repair Protein Expression and the Pathological Feature and Prognosis of Colorectal Cancer[J].Medical Information,2024,37(03):99.[doi:10.3969/j.issn.1006-1959.2024.08.019]
[5]袁茜宁,董怡晨,卿玲玲,等.不同蛋白尿水平IgA肾病患者的临床及病理特征分析[J].医学信息,2024,37(08):104.[doi:10.3969/j.issn.1006-1959.2024.08.020]
YUAN Qian-ning,DONG Yi-chen,QING Ling-ling,et al.Analysis of Clinical and Pathological Characteristics of IgA Nephropathy Patients with Different Proteinuria Levels[J].Medical Information,2024,37(03):104.[doi:10.3969/j.issn.1006-1959.2024.08.020]